Digital therapeutics lead to clinically significant body weight loss in patients with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.
Somaya AlbhaisiJustin TondtJohn CyrusVernon M ChinchilliDavid E ConroyJonathan G StinePublished in: Hepatology communications (2024)
DTx-delivered lifestyle intervention programs lead to greater amounts of body weight loss than traditional in-person lifestyle counseling. These results further support the role of DTx in delivering lifestyle intervention programs to patients with metabolic dysfunction-associated steatotic liver disease and suggest that this scalable intervention offers promise to benefit the billions of patients worldwide with this condition.
Keyphrases
- weight loss
- bariatric surgery
- randomized controlled trial
- roux en y gastric bypass
- gastric bypass
- metabolic syndrome
- end stage renal disease
- public health
- oxidative stress
- physical activity
- cardiovascular disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- glycemic control
- small molecule
- obese patients
- prognostic factors
- type diabetes
- big data
- patient reported outcomes
- patient reported
- hepatitis c virus
- men who have sex with men